GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Adcock Ingram Holdings Ltd (JSE:AIP) » Definitions » YoY EPS Growth

Adcock Ingram Holdings (JSE:AIP) YoY EPS Growth : 0.21% (As of Dec. 2023)


View and export this data going back to 2008. Start your Free Trial

What is Adcock Ingram Holdings YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Adcock Ingram Holdings's YoY EPS Growth for the quarter that ended in Dec. 2023 was 0.21%.

Adcock Ingram Holdings's Earnings per Share (Diluted) for the six months ended in Dec. 2023 was R2.84.


Adcock Ingram Holdings YoY EPS Growth Historical Data

The historical data trend for Adcock Ingram Holdings's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adcock Ingram Holdings YoY EPS Growth Chart

Adcock Ingram Holdings Annual Data
Trend Sep13 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.87 -3.82 -0.48 22.62 12.95

Adcock Ingram Holdings Semi-Annual Data
Mar14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 29.81 16.22 17.02 8.91 0.21

Adcock Ingram Holdings YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Adcock Ingram Holdings's YoY EPS Growth for the fiscal year that ended in Jun. 2023 is calculated as:

YoY EPS Growth (A: Jun. 2023 )
=(Earnings per Share (Diluted) (A: Jun. 2023 )-Earnings per Share (Diluted) (A: Jun. 2022 ))/ | Earnings per Share (Diluted) (A: Jun. 2022 ) |
=(5.486-4.857)/ | 4.857 |
=12.95 %

Adcock Ingram Holdings's YoY EPS Growth for the quarter that ended in Dec. 2023 is calculated as:

YoY EPS Growth (Q: Dec. 2023 )
=(Earnings per Share (Diluted) (Q: Dec. 2023 )-Earnings per Share (Diluted) (Q: Dec. 2022 )) / | Earnings per Share (Diluted) (Q: Dec. 2022 )) |
=(2.839-2.833)/ | 2.833 |
=0.21 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adcock Ingram Holdings YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Adcock Ingram Holdings's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Adcock Ingram Holdings (JSE:AIP) Business Description

Traded in Other Exchanges
N/A
Address
1 New Road, (c/o New Road & 7th Street), Midrand, Johannesburg, GT, ZAF, 1682
Adcock Ingram Holdings Ltd is a drug manufacturing company. The company manufactures, markets, and distributes a wide range of healthcare products. The company generates roughly two-thirds of its sales from the private sector, with the remaining from the public sector. Adcock operates in four broad areas: renal disease, medicine delivery, transfusion therapies, and blood and specialized pharmaceuticals. The company generates the vast majority of its revenue in southern Africa, followed by the rest of Africa and India.